Get startedLog in
    Picture of Radiopharm Theranostics logo

    RAD — Radiopharm Theranostics News Story

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Radiopharm Theranostics To Start Rv-01 Study In 4Q25

    Picture of Radiopharm Theranostics logoRadiopharm Theranostics
    28/07/2025 13:01
    July 28 (Reuters) - Radiopharm Theranostics Ltd RAD.AX:

RADIOPHARM THERANOSTICS RECEIVES IND APPROVAL FROM US FDA TO INITIATE PHASE I THERAPEUTIC CLINICAL STUDY TO TARGET B7H3 WITH BETABART (RV-01)

RADIOPHARM THERANOSTICS LTD - TO START RV-01 STUDY IN 4Q25

Source text: ID:nGNX6vyWQC

Further company coverage: RAD.AX

 (Reporting by Anshi Sancheti)

 ((Anshi.Sancheti@thomsonreuters.com;))

    Recent news on Radiopharm Theranostics

    See all news